It has been reported that PLK1 is frequently over-expressed in numerous cancers (such as esophageal cancer, colon cancer, breast cancer, non-small cell lung cancer, endometrial cancer, etc.), and facilitates the occurrence and progress of these cancers acting as an oncogene (26). This evidence concerns the gene PLK1 and cancer.